The silencing of CERS2 is able to increase V-ATPase activity and the extracellular hydrogen ion concentration and, in turn, the activation of secreted matrix metalloproteinase, leading to a decrease in extracellular pH that allows cell proliferation, cell survival, and cell invasion in vitro, as well as acceleration in BC growth in vivo [12]. Here, CERS2 is linked to breast cancer.